These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 9412944)

  • 1. Pravastatin has no effect on bile lipid composition, nucleation time, and gallbladder motility in persons with normal levels of cholesterol.
    Sharma BC; Agarwal DK; Baijal SS; Saraswat VA
    J Clin Gastroenterol; 1997 Sep; 25(2):433-6. PubMed ID: 9412944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effects of the 3-hydroxy, 3-methylglutaryl coenzyme A reductase inhibitor pravastatin on bile composition and nucleation of cholesterol crystals in cholesterol gallstone disease.
    Smit JW; van Erpecum KJ; Renooij W; Stolk MF; Edgar P; Doornewaard H; Vanberge-Henegouwen GP
    Hepatology; 1995 Jun; 21(6):1523-9. PubMed ID: 7768495
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cisapride improves gallbladder emptying and bile lipid composition in patients with gallstones.
    Dhiman RK; Reddi R; Sharma A; Singh R; Kohli KK; Gupta S; Suri S; Chawla Y
    J Gastroenterol Hepatol; 2001 Jul; 16(7):816-20. PubMed ID: 11446892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bile lithogenicity and gallbladder emptying in patients with microlithiasis: effect of bile acid therapy.
    Sharma BC; Agarwal DK; Dhiman RK; Baijal SS; Choudhuri G; Saraswat VA
    Gastroenterology; 1998 Jul; 115(1):124-8. PubMed ID: 9649467
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of endoscopic sphincterotomy on gall bladder bile lithogenicity and motility.
    Sharma BC; Agarwal DK; Baijal SS; Negi TS; Choudhuri G; Saraswat VA
    Gut; 1998 Feb; 42(2):288-92. PubMed ID: 9536957
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of long-term treatment with low-dose pravastatin on biliary lipid and bile acid composition in patients with nonfamilial hyperlipoproteinemia.
    Tazuma S; Takizawa I; Kunita T; Mizuno T; Watanabe T; Teramen K; Horikawa K; Ochi H; Yamashita Y; Aihara N
    Metabolism; 1995 Nov; 44(11):1410-2. PubMed ID: 7476326
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid composition and cholesterol nucleation time in gallbladder bile of patients with cholesterol gallstones under choleretic treatment with Febuprol.
    Jüngst D; Brenner G; Pratschke E; Paumgartner G
    Z Gastroenterol; 1988 May; 26(5):275-8. PubMed ID: 3407249
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the HMG-CoA reductase inhibitor pravastatin influence nucleation of cholesterol crystals in supersaturated model bile?
    Smit JW; Van Erpecum KJ; Gadella MM; Van de Heyning BJ; Van Berge-Henegouwen GP
    Eur J Gastroenterol Hepatol; 1996 Mar; 8(3):197-200. PubMed ID: 8724016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of simvastatin and cholestyramine on bile lipid composition and gall bladder motility in patients with hypercholesterolaemia.
    Smit JW; Van Erpecum KJ; Portincasa P; Renooij W; Erkelens DW; Van Berge-Henegouwen GP
    Gut; 1995 Nov; 37(5):654-9. PubMed ID: 8549941
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alterations in gallbladder emptying and bile retention in the absence of changes in bile lithogenicity in postmenopausal women on hormone replacement therapy.
    Dhiman RK; Sarkar PK; Sharma A; Vasishta K; Kohli KK; Gupta S; Suri S; Chawla Y
    Dig Dis Sci; 2004 Aug; 49(7-8):1335-41. PubMed ID: 15387365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The relation between biliary lipids, nucleation time, and number of gallbladder stones after percutaneous gallbladder puncture.
    Tudyka J; Kratzer W; Maier C; Mason R; Wechsler JG
    Scand J Gastroenterol; 1994 Sep; 29(9):844-8. PubMed ID: 7824866
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cisapride improves gallbladder contractility and bile lipid composition in an animal model of gallstone disease.
    Xu QW; Shaffer EA
    Gastroenterology; 1993 Oct; 105(4):1184-91. PubMed ID: 8405865
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of the prokinetic agent, erythromycin, in the Richardson ground squirrel model of cholesterol gallstone disease.
    Xu QW; Scott RB; Tan DT; Shaffer EA
    Hepatology; 1998 Sep; 28(3):613-9. PubMed ID: 9731548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gallbladder emptying in vivo, bile composition, and nucleation of cholesterol crystals in patients with cholesterol gallstones.
    Stolk MF; van Erpecum KJ; Renooij W; Portincasa P; van de Heijning BJ; vanBerge-Henegouwen GP
    Gastroenterology; 1995 Jun; 108(6):1882-8. PubMed ID: 7768394
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pravastatin activates PPARalpha/PPARgamma expression in the liver and gallbladder epithelium of hamsters.
    Dong SH; Lee J; Koh DH; Choi MH; Jang HJ; Kae SH
    Hepatobiliary Pancreat Dis Int; 2011 Apr; 10(2):185-90. PubMed ID: 21459726
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The pravastatin-induced decrease of biliary cholesterol secretion is not directly related to an inhibition of cholesterol synthesis in humans.
    Kallien G; Lange K; Stange EF; Scheibner J
    Hepatology; 1999 Jul; 30(1):14-20. PubMed ID: 10385633
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Simvastatin, a competitive inhibitor of HMG-CoA reductase, lowers cholesterol saturation index of gallbladder bile.
    Duane WC; Hunninghake DB; Freeman ML; Pooler PA; Schlasner LA; Gebhard RL
    Hepatology; 1988; 8(5):1147-50. PubMed ID: 3047037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibitory effects of pravastatin, a competitive inhibitor of hydroxymethylglutaryl coenzyme A reductase, on cholesterol gallstone formation in prairie dogs.
    Tazuma S; Hatsushika S; Aihara N; Sagawa H; Yamashita G; Sasaki M; Sasaki H; Mizuno S; Tao S; Kajiyama G
    Digestion; 1992; 51(3):179-84. PubMed ID: 1521718
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dissolution of gallstones with simvastatin, an HMG CoA reductase inhibitor.
    Chapman BA; Burt MJ; Chisholm RJ; Allan RB; Yeo KH; Ross AG
    Dig Dis Sci; 1998 Feb; 43(2):349-53. PubMed ID: 9512129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of fluvastatin on human biliary lipids.
    Tazuma S; Ohya T; Mizuno T; Takizawa I; Kunita T; Takata K; Hayashi K; Hino F; Tokumo H; Watanabe T
    Am J Cardiol; 1995 Jul; 76(2):110A-113A. PubMed ID: 7604783
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.